Status:

NOT_YET_RECRUITING

QL1706/Bevacizumab ± Chemotherapy in Post-ICI Non-Squamous NSCLC

Lead Sponsor:

Guangdong Association of Clinical Trials

Conditions:

NSCLC

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The goal of this clinical trial is to evaluate QL1706 plus bevacizumab with or without chemotherapy in patients with PD-L1-negative, locally advanced or metastatic non-squamous non-small cell lung can...

Eligibility Criteria

Inclusion

  • Signed an informed consent form
  • Patients aged ≥18
  • Histologically or cytologically confirmed stage III or IV non-squamous non-small cell lung cancer (NSCLC) per the American Joint Committee on Cancer (AJCC) 8th Edition staging system
  • at least one measurable lesion according to RECIST 1.1 criteria
  • ECOG PS 0-1.
  • Subjects must have adequately documented disease progression following prior treatment with PD-1/PD-L1 inhibitors (administered as monotherapy or in combination with chemotherapy)
  • 8\. The most recent tumor tissue sample prior to the first dose of the study drug demonstrated PD-L1 TPS \<1% 9. appropriate organ function

Exclusion

  • Known presence of sensitizing mutations in EGFR, EGFR exon 20 insertions, ALK fusions, ROS1 fusions, RET fusions, NTRK fusions, BRAF V600E mutations, MET exon 14 skipping mutations, or HER2 sensitizing mutations (for other genetic alterations, eligibility will be determined by the Biomarker Committee on a case-by-case basis).
  • Patients with symptomatic, neurologically unstable central nervous system (CNS) metastases, or CNS diseases that require increased steroid doses to control
  • Prior lines of systemic anti-tumor therapy ≥ 2.

Key Trial Info

Start Date :

August 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2029

Estimated Enrollment :

77 Patients enrolled

Trial Details

Trial ID

NCT07134413

Start Date

August 1 2025

End Date

July 1 2029

Last Update

August 21 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

QL1706/Bevacizumab ± Chemotherapy in Post-ICI Non-Squamous NSCLC | DecenTrialz